134 related articles for article (PubMed ID: 32281553)
1. Determinant Factors on Differences in Survival for Gastric Cancer Between the United States and Japan Using Nationwide Databases.
Ito Y; Miyashiro I; Ishikawa T; Akazawa K; Fukui K; Katai H; Nunobe S; Oda I; Isobe Y; Tsujitani S; Ono H; Tanabe S; Fukagawa T; Suzuki S; Kakeji Y; Sasako M; Bilchik A; Fujita M
J Epidemiol; 2021 Apr; 31(4):241-248. PubMed ID: 32281553
[TBL] [Abstract][Full Text] [Related]
2. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
Smith DD; Schwarz RR; Schwarz RE
J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
[TBL] [Abstract][Full Text] [Related]
3. Is gastric carcinoma different between Japan and the United States?
Noguchi Y; Yoshikawa T; Tsuburaya A; Motohashi H; Karpeh MS; Brennan MF
Cancer; 2000 Dec; 89(11):2237-46. PubMed ID: 11147594
[TBL] [Abstract][Full Text] [Related]
4. Necessity of harvesting at least 25 lymph nodes in patients with stage N2-N3 resectable gastric cancer: a 10-year, single-institution cohort study.
Chen HN; Chen XZ; Zhang WH; Chen XL; Yang K; Liu JP; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Medicine (Baltimore); 2015 Mar; 94(10):e620. PubMed ID: 25761190
[TBL] [Abstract][Full Text] [Related]
5. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
6. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.
Schwarz RE; Smith DD
Ann Surg Oncol; 2007 Feb; 14(2):317-28. PubMed ID: 17094022
[TBL] [Abstract][Full Text] [Related]
7. A modified subclassification to evaluate the survival of patients with N3 gastric cancer: an international database study.
Lin MQ; Wang JB; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; He QL; Huang CM
BMC Cancer; 2019 Jan; 19(1):21. PubMed ID: 30616588
[TBL] [Abstract][Full Text] [Related]
8. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of a new staging system based on the retrieved number and metastatic rate of LNs in gastric cancer with ≤15 retrieved LNs.
Tu RH; Lin JX; Wang W; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zhou ZW; Zheng CH; Huang CM
Eur J Surg Oncol; 2020 Dec; 46(12):2221-2228. PubMed ID: 32859432
[TBL] [Abstract][Full Text] [Related]
10. Survival Analysis with Extended Lymphadenectomy for Gastric Cancer: Removing Stage Migration from the Equation.
Vuong B; Graff-Baker AN; Dehal A; Stern S; Fujita M; Goldfarb M; Bilchik AJ
Am Surg; 2017 Oct; 83(10):1074-1079. PubMed ID: 29391098
[TBL] [Abstract][Full Text] [Related]
11. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.
Son T; Hyung WJ; Lee JH; Kim YM; Kim HI; An JY; Cheong JH; Noh SH
Cancer; 2012 Oct; 118(19):4687-93. PubMed ID: 22415925
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
Strong VE; Song KY; Park CH; Jacks LM; Gonen M; Shah M; Coit DG; Brennan MF
Ann Surg; 2010 Apr; 251(4):640-6. PubMed ID: 20224369
[TBL] [Abstract][Full Text] [Related]
13. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
Coburn NG; Swallow CJ; Kiss A; Law C
Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
[TBL] [Abstract][Full Text] [Related]
14. Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis.
Pan S; Wang P; Xing Y; Li K; Wang Z; Xu H; Zhu Z
Cancer Commun (Lond); 2019 Sep; 39(1):49. PubMed ID: 31519217
[TBL] [Abstract][Full Text] [Related]
15. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
[TBL] [Abstract][Full Text] [Related]
16. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
18. Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients.
Kutlu OC; Watchell M; Dissanaike S
Surg Oncol; 2015 Jun; 24(2):84-8. PubMed ID: 25912951
[TBL] [Abstract][Full Text] [Related]
19. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base.
Datta J; Lewis RS; Mamtani R; Stripp D; Kelz RR; Drebin JA; Fraker DL; Karakousis GC; Roses RE
Cancer; 2014 Sep; 120(18):2855-65. PubMed ID: 24854027
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry.
Nashimoto A; Akazawa K; Isobe Y; Miyashiro I; Katai H; Kodera Y; Tsujitani S; Seto Y; Furukawa H; Oda I; Ono H; Tanabe S; Kaminishi M
Gastric Cancer; 2013 Jan; 16(1):1-27. PubMed ID: 22729699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
